Roelcke U - Search Results

1

Imaging brain tumor proliferative activity with [124I]iododeoxyuridine.

Blasberg RG, Roelcke U, Weinreich R, Beattie B, von Ammon K, Yonekawa Y, Landolt H, Guenther I, Crompton NE, Vontobel P, Missimer J, Maguire RP, Koziorowski J, Knust EJ, Finn RD, Leenders KL. Blasberg RG, et al. Among authors: roelcke u. Cancer Res. 2000 Feb 1;60(3):624-35. Cancer Res. 2000. PMID: 10676646

2

PET imaging drug distribution after intratumoral injection: the case for (124)I-iododeoxyuridine in malignant gliomas.

Roelcke U, Hausmann O, Merlo A, Missimer J, Maguire RP, Freitag P, Radü EW, Weinreich R, Gratzl O, Leenders KL. Roelcke U, et al. J Nucl Med. 2002 Nov;43(11):1444-51. J Nucl Med. 2002. PMID: 12411546 Free article.

3

PET in neuro-oncology.

Roelcke U, Leenders KL. Roelcke U, et al. J Cancer Res Clin Oncol. 2001 Jan;127(1):2-8. doi: 10.1007/s004320000158. J Cancer Res Clin Oncol. 2001. PMID: 11206266 Review.

4

Crossed cerebellar diaschisis and brain tumor biochemistry studied with positron emission tomography, [18F]fluorodeoxyglucose and [11C]methionine.

Otte A, Roelcke U, von Ammon K, Hausmann O, Maguire RP, Missimer J, Müller-Brand J, Radü EW, Leenders KL. Otte A, et al. Among authors: roelcke u. J Neurol Sci. 1998;156(1):73-7. doi: 10.1016/s0022-510x(98)00019-7. J Neurol Sci. 1998. PMID: 9559990

5

Alteration of blood-brain barrier in human brain tumors: comparison of [18F]fluorodeoxyglucose, [11C]methionine and rubidium-82 using PET.

Roelcke U, Radü EW, von Ammon K, Hausmann O, Maguire RP, Leenders KL. Roelcke U, et al. J Neurol Sci. 1995 Sep;132(1):20-7. doi: 10.1016/0022-510x(95)00117-k. J Neurol Sci. 1995. PMID: 8523026

6

Brain tumor iron uptake measured with positron emission tomography and 52Fe-citrate.

Roelcke U, Leenders KL, von Ammon K, Radü EW, Vontobel P, Günther I, Psylla M. Roelcke U, et al. J Neurooncol. 1996 Aug;29(2):157-65. doi: 10.1007/BF00182139. J Neurooncol. 1996. PMID: 8858521

7

Tracer transport and metabolism in a patient with juvenile pilocytic astrocytoma. A PET study.

Roelcke U, Radü EW, Hausmann O, Vontobel P, Maguire RP, Leenders KL. Roelcke U, et al. J Neurooncol. 1998 Feb;36(3):279-83. doi: 10.1023/a:1005898109520. J Neurooncol. 1998. PMID: 9524106

8

Dexamethasone treatment and plasma glucose levels: relevance for fluorine-18-fluorodeoxyglucose uptake measurements in gliomas.

Roelcke U, Blasberg RG, von Ammon K, Hofer S, Vontobel P, Maguire RP, Radü EW, Herrmann R, Leenders KL. Roelcke U, et al. J Nucl Med. 1998 May;39(5):879-84. J Nucl Med. 1998. PMID: 9591593 Free article.

9

Positron emission tomography in patients with primary CNS lymphomas.

Roelcke U, Leenders KL. Roelcke U, et al. J Neurooncol. 1999 Jul;43(3):231-6. doi: 10.1023/a:1006202402010. J Neurooncol. 1999. PMID: 10563428 Review.

10

[76Br]Bromodeoxyuridine PET in tumor-bearing animals.

Gardelle O, Roelcke U, Vontobel P, Crompton NE, Guenther I, Bläuenstein P, Schubiger AP, Blattmann H, Ryser JE, Leenders KL, Kaser-Hotz B. Gardelle O, et al. Among authors: roelcke u. Nucl Med Biol. 2001 Jan;28(1):51-7. doi: 10.1016/s0969-8051(00)00189-x. Nucl Med Biol. 2001. PMID: 11182564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters